Protein_Kinase

Similar documents
QuickScout Screening Assist Kits from Carna Biosciences, Inc. Tyrosine Kinases ABL(ABL1) ABL(ABL1) [E255K] ABL(ABL1) [T315I] ACK(TNK2) ALK ALK [C1156Y


Biotinylated Kinases BTNABL(ABL1) Tyrosineprotein kinase ABL1 Biotinylated N 2 Nterminal DYKDDDDK カルタヘナ 80 BTNACTR2B(ACVR2B) Activin r

<4D F736F F F696E74202D20834A838B836982CC8E968BC693E097655F92868AFA8C7689E682CC82B290E096BE E707074>

サイトメトリー12-1.indd

AMPKα 2/ β 1/ γ 1(PRKAA2/B1/G1) 5'AMPactivated protein kinase CAMK グループに分類されるセリンスレオニンキナーゼ α β γ 鎖からなる 細胞内の ATP レベルの減少に対し ATP 消

<4D F736F F D2095BD8A8A8BD881458D758B608E9197BF F95BD96EC2E646F63>

品名 メーカーコード コード No. 容量希望納入価格 ( 円 ) BARK2(ADRBK2) Betaadrenergic receptor kinase 主に脳に発現する G タンパク受容体共役受容体キナーゼ (GRK) の一種 リガンドを結合

ゲノム解読による腫瘍の理解 n どの遺伝子異常が起こる? どういった分子経路の異常が腫瘍発生に寄与するのか? n どの遺伝子異常が治療標的となりうるか? 治療法の開発 n どういったゲノム異常が起こっているのか? 発がん要因の解明と予防法の開発 2

CML 旭川 CML 座談会 CML の治療戦略 :TKI free を目指して CMR 司会 出席者 コメンテーター 生田克哉先生 3 幸田久平先生 佐藤一也先生 柿木康孝先生 進藤基博先生 3 木村晋也先生 CML 生田 1 TKI CML 2 TKI 生田克哉先生 CML TKI CMR CM

PathScan Antibody Array Kits

好中球とPTX3

S _次世代冊子All_非アウトライン

MAP MAP MAP MAPKKK /MAP MAPKK /MAP MAPK MAPK MAP Microtubule associated protein 2 MAP Dundee Sturgill MAP MAP ERK1 ERK2 MAP Nerve Growth Factor NGF MA

日本内科学会雑誌第97巻第3号

_統合化推進プログラム_金久チーム_サイトビジット資料

放射線専門医認定試験(2009・20回)/HOHS‐01(基礎一次)

tnbp59-17_Web:プO1/ky079888509610003201

Untitled

総括研究成果報告書

BTR 6110BTR CTC CTC CTC-HER2-1 -

第86回日本感染症学会総会学術集会後抄録(II)

岩見グループ合宿160816提出用

dプログラム_1

PowerPoint プレゼンテーション

CAMKK1 Calcium/calmodulindependent protein kinase kinase カルシウム カルモジュリンの結合により活性化し CaM Kinase I, IV をリン酸化することによってその活性を向上させ 様々な

品名 メーカーコード コード No. 容量希望納入価格 ( 円 ) ARG(ABL2) Abelson tyrosineprotein kinase TK グループに分類される非受容体型チロシンキナーゼ ABL1 と重複した機能を持ち 細胞骨格の再

研究成果報告書

IonTorrentPGM_appnote_0319.indd

受賞講演要旨2012cs3

細胞周期とチェックポイント

第79回_プログラム.indd

H26分子遺伝-19(免疫系のシグナル).ppt

Doi: /electroph.61.9 Phos-tag SDS-PAGE MEK1 * SUMMARY MEK1, a chief component of the mitogen-activated protein

一般演題(ポスター)

基礎数学I

ミニレビュー

higp-15(プロ1日目)/ky220147284100029951

肺癌第50巻第4号

CDK2/CycA2 Cyclindependent kinase CMGC グループに分類されるセリンスレオニンキナーゼ 細胞周期チェックポイントの制御に関与する 減数分裂に必須だが体細胞分裂には必須ではない S 期と G2 期に活性が極大となる

新技術説明会 様式例

第85 回日本感染症学会総会学術集会後抄録(I)


日本内科学会雑誌第98巻第3号


yakuri06023‡Ì…R…s†[

Tocris 社製品ガイドシリーズ 目次 当製品ガイドには キノームグループ (AGC CAMK CK1 CMGC TE TK TKL) 別に分類したさまざまな種類のプロテインキナーゼ阻害剤を始め 300 種類を超える Tocris 社製品が掲載されています また ホスファターゼ阻害剤に加え 非定型

論文の内容の要旨

第52回日本生殖医学会総会・学術講演会

Human genome near complete: Oct. 21, 2004, Nature Sequencing SNPs HapMap Non-coding Sequence Histon-DNA, RNAi Pathway/Network Systems Biology Digital


jigp60-★WEB用★/ky494773452500058730

プログラム

研究成果報告書


日本内科学会雑誌第102巻第12号


ito.dvi

第85 回日本感染症学会総会学術集会後抄録(III)

第101回 日本美容外科学会誌/nbgkp‐01(大扉)

27巻3号/FUJSYU03‐107(プログラム)

パーキンソン病治療ガイドライン2002

本文27/A(CD-ROM

tnbp59-20_Web:P1/ky108679509610002943


研究会プログラム.doc

I II III 28 29

生活設計レジメ

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)


Microsoft PowerPoint

untitled

スライド 1

Driver gene 発見による希少 fraction での開発 ( 肺腺がん ) Approved and Potentially effective molecular targeting agents( 肺腺癌 ) KRAS unknown EGFR RET fusion * ROS fus

スライド 1


m «É w «Ÿ ÉÉ É É ÉÉ É É

研究成果報告書(基金分)

0120

資料 4 臨床側が目指すゲノム医療 (TOP-GEAR プロジェクト ) 国立がん研究センター企画戦略局長 同 中央病院 副院長 ( 研究担当 ) 乳腺 腫瘍内科 藤原 康弘 National Cancer Center Hospital

2


日本糖尿病学会誌第58巻第3号

学位論文の内容の要旨 論文提出者氏名 小川憲人 論文審査担当者 主査田中真二 副査北川昌伸 渡邉守 論文題目 Clinical significance of platelet derived growth factor -C and -D in gastric cancer ( 論文内容の要旨 )

ABN”Ð…J…^…“…OP01-24.indd

ABSTRACT

計算機生命科学の基礎II_

Microsoft Word - 第56回日本脂質生化学会プログラムv1.doc

24.15章.微分方程式

PowerPoint Presentation

日本糖尿病学会誌第58巻第2号

indd

計画研究 年度 高血圧発症関連遺伝子群の解明 羽田 明1 蒔田芳男2 菊池健次郎2 井ノ上逸朗3 島本和明4 藤原拓也5 梅村 杉山卓郎7 江藤胤尚8 塩飽邦憲9 並河 徹9 高橋規郎10 敏6 1 千葉大学大学院医学研究院 2 旭川医科大学 3 東京大学医科学研究所 4 札幌医科

204 / CHEMISTRY & CHEMICAL INDUSTRY Vol.69-1 January

Proceedings of the Society 78

( 報告様式 4) 16cm h0001 平成 29 年 5 月 30 日 平成 28 年度委託研究開発成果報告書 I. 基本情報 事業名 : ( 日本語 ) 次世代がん医療創生研究事業 ( 英語 ) Project for Cancer Research and Therapeutic

OriGene 社 ヒトがん組織 正常組織関連製品 OriGene 社は 140,000 を超えるヒト組織サンプルを保有しています 全ての組織サンプルは 厳しい倫理的な要件と IRB( 倫理委員会 ) のプロトコールに基づいて米国の医療センターから収集され 認定された病理学者により がん 正常 その

Folia Pharmacol. Jpn mg/14 ml mg/ ml Genentech, Inc. Genentech HER human epidermal growth factor receptor type HER - HER HER HER HER

9 : : : : : : : : : 00

COI開示及び免責事項 発表者名 矢花直幸 演題発表に関連し 開示すべきCOI関係にある企 業などはありません また本講演の内容は発表者の個人的見解を含む ものであり PMDAの公式の見解ではありません 2

Transcription:

Protein Kinase 355 個 (2012/4/1 現在 ) 遺伝子シンボル説明 FXC_PID 価格 FHC_PID 価格 AAK1 AP2 associated kinase 1 FXC00722 40,000 FHC00722 50,000 AATK apoptosis-associated tyrosine kinase FXC04004 40,000 FHC04004M 60,000 ABL1 c-abl oncogene 1, receptor tyrosine kinase FXC01406 40,000 FHC01406 50,000 ACTR2 ARP2 actin-related protein 2 homolog (yeast) FXC02146 40,000 FHC02146 50,000 ACVR1 Activin receptor type-1 Precursor (EC 2.7.11.30)(Activin receptor type I)(ACTR-I)(Serine/threonine-protein kinase receptor R1)(SKR1)(Activin receptor-like kinase 2)(ALK- FXC03971 40,000 FHC03971 50,000 2)(TGF-B superfamily receptor type I)(TSR-I) ACVR1B activin A receptor, type IB FXC01408 40,000 FHC01408 50,000 ACVR1C activin A receptor, type IC FXC09109M 50,000 FHC09109 50,000 ACVRL1 activin A receptor type II-like 1, transcript variant 1 FXC28135M 50,000 FHC28135 50,000 ADRBK1 adrenergic, beta, receptor kinase 1 FXC09648M 50,000 FHC09648 50,000 ADRBK2 adrenergic, beta, receptor kinase 2 FXC27231M 50,000 FHC27231 50,000 AKT1 v-akt murine thymoma viral oncogene homolog 1 FXC02215 40,000 FHC02215 50,000 AKT2 v-akt murine thymoma viral oncogene homolog 2 FXC26633 40,000 FHC26633 50,000 AKT3 v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) FXC02812 40,000 FHC02812 50,000 ALK anaplastic lymphoma receptor tyrosine kinase FXC00337 40,000 FHC00337 50,000 ARAF A-Raf proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1)(A-raf-1)(Proto-oncogene Pks) FXC08066 40,000 FHC08066 50,000 AURKA aurora kinase A FXC02742 40,000 FHC02742 50,000 AURKC aurora kinase C FXC11256 40,000 FHC11256 50,000 AXL AXL receptor tyrosine kinase FXC01861 40,000 FHC01861 50,000 BLK Tyrosine-protein kinase BLK (EC 2.7.10.2)(B lymphocyte kinase)(p55-blk) FXC03808 40,000 FHC03808 50,000 BMPR1A bone morphogenetic protein receptor, type IA FXC09257 40,000 FHC09257 50,000 BMPR1B Bone morphogenetic protein receptor type-1b Precursor (EC 2.7.11.30)(CDw293 antigen) FXC03435 40,000 FHC03435 50,000 BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) FXC01318 40,000 FHC01318 50,000 BMX BMX non-receptor tyrosine kinase FXC08849 40,000 FHC08849 50,000 BRAF B-Raf proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1)(p94)(v-Raf murine sarcoma viral oncogene homolog FXC11883 40,000 FHC11883 50,000 BRSK2 BR serine/threonine kinase 2 FXC29626M 50,000 FHC29626 50,000 BTK Tyrosine-protein kinase BTK (EC 2.7.10.2)(Bruton tyrosine kinase)(agammaglobulinaemia tyrosine kinase)(atk)(b-cell FXC05404M 50,000 FHC05404 50,000 progenitor kinase)(bpk) CAMK1 calcium/calmodulin-dependent protein kinase I FXC11206 40,000 FHC11206 50,000 CAMK1D calcium/calmodulin-dependent protein kinase ID FXC11216 40,000 FHC11216 50,000 CAMK2A calcium/calmodulin-dependent protein kinase II alpha FXC00158 40,000 FHC00158 50,000 CAMK2B calcium/calmodulin-dependent protein kinase II beta FXC04424 40,000 FHC04424 50,000 CAMK2D calcium/calmodulin-dependent protein kinase II delta FXC01765 40,000 FHC01765 50,000 CAMK2G calcium/calmodulin-dependent protein kinase II gamma FXC10307M 50,000 FHC10307 50,000 CAMK4 calcium/calmodulin-dependent protein kinase IV FXC11417 40,000 FHC11417 50,000 CAMKK1 calcium/calmodulin-dependent protein kinase kinase 1, alpha FXC10271M 50,000 FHC10271 50,000 CAMKK2 calcium/calmodulin-dependent protein kinase kinase 2, beta FXC09184M 50,000 FHC09184 50,000 CAMKV CaM kinase-like vesicle-associated FXC07876M 50,000 FHC07876 50,000 CASK Peripheral plasma membrane protein CASK (hcask)(ec 2.7.11.1)(Calcium/calmodulin-dependent serine protein FXC04437M 50,000 FHC04437 50,000 kinase)(lin-2 homolog) CDC42BPA CDC42 binding protein kinase alpha (DMPK-like) FXC01284 40,000 FHC01284 50,000 CDC42BPB CDC42 binding protein kinase beta (DMPK-like) FXC00181 40,000 FHC00181 50,000 CDC7 cell division cycle 7 homolog (S. cerevisiae) FXC10990M 50,000 FHC10990 50,000 CDK10 cyclin-dependent kinase 10 FXC02837 40,000 FHC02837 50,000 CDK11A cyclin-dependent kinase 11A FXC11114M 50,000 FHC11114 50,000 CDK12 cyclin-dependent kinase 12 (CDK12), transcript variant 2, FXC02002 40,000 FHC02002 50,000 CDK12 cyclin-dependent kinase 12, transcript variant 1 FXC25993M 120,000 FHC25993M 130,000 CDK15 cyclin-dependent kinase 15 FXC11569M 50,000 FHC11569 50,000 CDK17 cyclin-dependent kinase 17, transcript variant 1 FXC09466M 50,000 FHC09466 50,000 CDK2 cyclin-dependent kinase 2 FXC02738 40,000 FHC02738 50,000 CDK20 cyclin-dependent kinase 20, transcript variant 3 FXC23550M 50,000 FHC23550 50,000 CDK3 Cell division protein kinase 3 (EC 2.7.11.22) FXC03928 40,000 FHC03928 50,000 CDK4 Cell division protein kinase 4 (EC 2.7.11.22)(Cyclindependent kinase 4)(PSK-J3) FXC08159 40,000 FHC08159 50,000 CDK5 cyclin-dependent kinase 5 FXC02662 40,000 FHC02662 50,000 CDK6 cyclin-dependent kinase 6 FXC10565 40,000 FHC10565 50,000 CDK7 cyclin-dependent kinase 7 FXC01723 40,000 FHC01723 50,000 CDK8 cyclin-dependent kinase 8 FXC24966M 50,000 FHC24966 50,000

CDK9 cyclin-dependent kinase 9 FXC08042M 50,000 FHC08042 50,000 CDKL1 cyclin-dependent kinase-like 1 (CDC2-related kinase) FXC25164M 50,000 FHC25164 50,000 CDKL2 cyclin-dependent kinase-like 2 (CDC2-related kinase) FXC21962M 50,000 FHC21962 50,000 CDKL3 cyclin-dependent kinase-like 3, transcript variant 1 FXC31101M 50,000 FHC31101 50,000 CDKL4 cyclin-dependent kinase-like 4 FXC28701M 50,000 FHC28701 50,000 CDKL5 cyclin-dependent kinase-like 5 FXC10738 40,000 FHC10738 50,000 CHEK1 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) FXC03424 40,000 FHC03424 50,000 CHEK2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1)(Cds1) FXC04554 40,000 FHC04554 50,000 CHUK conserved helix-loop-helix ubiquitous kinase FXC10858M 50,000 FHC10858 50,000 CIT citron (rho-interacting, serine/threonine kinase 21) FXC00156 40,000 FHC00156 50,000 CSF1R colony stimulating factor 1 receptor FXC10479 40,000 FHC10479 50,000 CSK Tyrosine-protein kinase CSK (EC 2.7.10.2)(C-SRC kinase)(protein-tyrosine kinase CYL) FXC03488 40,000 FHC03488 50,000 CSNK1A1 casein kinase 1, alpha 1 FXC01538 40,000 FHC01538 50,000 CSNK1A1L casein kinase 1, alpha 1-like FXC09266 40,000 FHC09266 50,000 CSNK1D Casein kinase I isoform delta (CKI-delta)(CKId)(EC 2.7.11.1) FXC03511 40,000 FHC03511 50,000 CSNK1E casein kinase 1, epsilon FXC01335 40,000 FHC01335 50,000 CSNK1G1 casein kinase 1, gamma 1 FXC11258 40,000 FHC11258 50,000 CSNK1G2 casein kinase 1, gamma 2 FXC11254 40,000 FHC11254 50,000 CSNK1G3 Casein kinase I isoform gamma-3 (CKI-gamma 3)(EC FXC10431 40,000 FHC10431 50,000 CSNK2A1 casein kinase 2, alpha 1 polypeptide FXC08568M 50,000 FHC08568 50,000 CSNK2A2 casein kinase 2, alpha prime polypeptide FXC04660 40,000 FHC04660 50,000 DAPK1 death-associated protein kinase 1 FXC01854 40,000 FHC01854 50,000 DAPK2 death-associated protein kinase 2 FXC25418M 50,000 FHC25418 50,000 DAPK3 death-associated protein kinase 3 FXC26400M 50,000 FHC26400 50,000 DCLK1 doublecortin-like kinase 1 FXC00061 40,000 FHC00061 50,000 DCLK2 doublecortin-like kinase 2 FXC01748 40,000 FHC01748 50,000 DDR1 discoidin domain receptor tyrosine kinase 1 FXC02069 40,000 FHC02069 50,000 DMPK dystrophia myotonica-protein kinase FXC01383 40,000 FHC01383 50,000 DYRK1B dual-specificity tyrosine-(y)-phosphorylation regulated kinase FXC01350 40,000 FHC01350 50,000 DYRK2 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) FXC03899 40,000 FHC03899 50,000 DYRK3 dual-specificity tyrosine-(y)-phosphorylation regulated kinase FXC11427 40,000 FHC11427 50,000 DYRK4 dual-specificity tyrosine-(y)-phosphorylation regulated kinase FXC11424 40,000 FHC11424 50,000 EGFR epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) FXC09683M 110,000 FHC09683M 120,000 EIF2AK1 Eukaryotic translation initiation factor 2-alpha kinase 1 FXC00817 40,000 FHC00817 50,000 EIF2AK2 eukaryotic translation initiation factor 2-alpha kinase 2, transcript variant 2 FXC20967M 50,000 FHC20967 50,000 EIF2AK2 eukaryotic translation initiation factor 2-alpha kinase 2, transcript variant 3 FXC20968M 50,000 FHC20968M 60,000 EIF2AK4 eukaryotic translation initiation factor 2 alpha kinase 4 FXC04866 40,000 FHC04866 50,000 EPHA2 EPH receptor A2 FXC09635M 50,000 FHC09635 50,000 EPHA3 EPH receptor A3 FXC01711 40,000 FHC01711 50,000 EPHA5 EPH receptor A5 FXC01385 40,000 FHC01385 50,000 EPHA7 EPH receptor A7 FXC10471 40,000 FHC10471 50,000 EPHA8 EPH receptor A8 FXC04904 40,000 FHC04904 50,000 EPHB1 EPH receptor B1 FXC31004M 50,000 FHC31004 50,000 EPHB2 EPH receptor B2 FXC01018 40,000 FHC01018 50,000 EPHB3 EPH receptor B3 FXC01841 40,000 FHC01841 50,000 EPHB4 EPH receptor B4 FXC23022M 50,000 FHC23022 50,000 EPHB6 EPH receptor B6 FXC01198 40,000 FHC01198 50,000 ERBB2 Receptor tyrosine-protein kinase erbb-2 Precursor (EC 2.7.10.1)(p185erbB2)(C-erbB-2)(NEU protooncogene)(tyrosine FXC11836 40,000 FHC11836M 60,000 kinase-type cell surface receptor ERBB3 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian), transcript variant 1 FXC28149M 50,000 FHC28149 50,000 ERBB4 Homo sapiens v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) (ERBB4), transcript variant JM-a/CVT-1 FXC21305M 110,000 FHC21305M 120,000 ERBB4 Homo sapiens v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) (ERBB4), transcript variant JM-a/CVT-2 FXC21306M 110,000 FHC21306M 120,000 ERN1 endoplasmic reticulum to nucleus signaling 1 FXC01530 40,000 FHC01530 50,000 FER Proto-oncogene tyrosine-protein kinase FER (c-fer)(ec 2.7.10.2)(p94-FER)(Tyrosine kinase 3) FXC03985M 50,000 FHC03985 50,000 FES feline sarcoma oncogene FXC11018M 50,000 FHC11018 50,000 FGFR1 Basic fibroblast growth factor receptor 1 Precursor (FGFR- 1)(bFGF-R)(EC 2.7.10.1)(Fms-like tyrosine kinase 2)(cfgr)(CD331 FXC10532 40,000 FHC10532 50,000 antigen) FGFR2 fibroblast growth factor receptor 2 FXC24041M 110,000 FHC24041M 120,000 FGFR3 fibroblast growth factor receptor 3 FXC10478 40,000 FHC10478 50,000 FGFR3 fibroblast growth factor receptor 3 FXC10468 40,000 FHC10468M 60,000

FGFR4 fibroblast growth factor receptor 4 FXC09979M 50,000 FHC09979 50,000 FGR Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene FXC20165M 50,000 FHC20165 50,000 FLT1 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) FXC01847 40,000 FHC01847 50,000 FLT3 fms-related tyrosine kinase 3 FXC28201M 90,000 FHC28201M 100,000 FRK fyn-related kinase FXC08658 40,000 FHC08658 50,000 FYN FYN oncogene related to SRC, FGR, YES FXC10684 40,000 FHC10684 50,000 GRK1 G protein-coupled receptor kinase 1 FXC11140M 50,000 FHC11140 50,000 GRK5 G protein-coupled receptor kinase 5 FXC24037M 50,000 FHC24037 50,000 GRK6 G protein-coupled receptor kinase 6 (EC 2.7.11.16)(G proteincoupled receptor kinase GRK6) FXC03530 40,000 FHC03530 50,000 GRK7 G protein-coupled receptor kinase 7 Precursor (EC 2.7.11.16)(G protein-coupled receptor kinase GRK7) FXC05362 40,000 FHC05362 50,000 GSK3A glycogen synthase kinase 3 alpha FXC09232M 50,000 FHC09232 50,000 GSK3B glycogen synthase kinase 3 beta FXC01477 40,000 FHC01477 50,000 GUCY2D guanylate cyclase 2D, membrane (retina-specific) FXC05382 40,000 FHC05382 50,000 HCK hemopoietic cell kinase FXC28810M 50,000 FHC28810 50,000 HIPK2 homeodomain interacting protein kinase 2 FXC11119M 50,000 FHC11119 50,000 HIPK3 homeodomain interacting protein kinase 3 FXC05423 40,000 FHC05423 50,000 ICK intestinal cell (MAK-like) kinase FXC00689 40,000 FHC00689 50,000 IGF1R insulin-like growth factor 1 receptor FXC01578 40,000 FHC01578 50,000 IKBKB Inhibitor of nuclear factor kappa-b kinase subunit beta (Ikappa-B-kinase beta)(ikbkb)(ikk-beta)(ikk-b)(ec 2.7.11.10)(I-kappa-B kinase 2)(IKK2)(Nuclear factor NFkappa-B FXC03657 40,000 FHC03657 50,000 inhibitor kinase beta)(nfkbikb) IKBKE inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon FXC00030 40,000 FHC00030 50,000 ILK integrin-linked kinase FXC02645 40,000 FHC02645 50,000 INSR insulin receptor FXC11132M 50,000 FHC11132 50,000 IRAK1 interleukin-1 receptor-associated kinase 1 FXC02774 40,000 FHC02774 50,000 IRAK2 Interleukin-1 receptor-associated kinase-like 2 (IRAK-2) FXC10544 40,000 FHC10544 50,000 IRAK3 interleukin-1 receptor-associated kinase 3 FXC24800M 50,000 FHC24800 50,000 IRAK4 interleukin-1 receptor-associated kinase 4 FXC08686M 50,000 FHC08686 50,000 ITK IL2-inducible T-cell kinase FXC10993M 50,000 FHC10993 50,000 JAK1 Tyrosine-protein kinase JAK1 (EC 2.7.10.2)(Janus kinase 1)(JAK-1) FXC01306 40,000 FHC01306 50,000 KALRN kalirin, RhoGEF kinase FXC00315 40,000 FHC00315 50,000 KDR kinase insert domain receptor (a type III receptor tyrosine FXC21921M 50,000 FHC21921 50,000 KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene FXC01839 40,000 FHC01839 50,000 LATS1 LATS, large tumor suppressor, homolog 1 (Drosophila) FXC29211M 50,000 FHC29211 50,000 LCK Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2)(Lymphocyte cell-specific protein-tyrosine FXC03736 40,000 FHC03736 50,000 kinase)(p56-lck)(lsk)(t cell-specific protein-tyrosine kinase) LIMK1 LIM domain kinase 1 FXC00359 40,000 FHC00359 50,000 LIMK2 LIM domain kinase 2 (LIMK-2)(EC 2.7.11.1) FXC05834 40,000 FHC05834 50,000 LMTK2 lemur tyrosine kinase 2 FXC00174 40,000 FHC00174 50,000 LMTK2 Serine/threonine-protein kinase LMTK2 Precursor (EC 2.7.11.1)(Lemur tyrosine kinase 2)(Serine/threonine protein kinase KPI-2)(Kinase/phosphatase/inhibitor 2)(Apoptosisassociated FXC05532M 50,000 FHC05532 50,000 tyrosine kinase 2)(Brain-enriched kinase)(hbrek)(cdk5/p35-regulated kinase)(cprk) LMTK3 lemur tyrosine kinase 3 FXC00294 40,000 FHC00294M 60,000 LYN Tyrosine-protein kinase Lyn (EC 2.7.10.2) FXC03444 40,000 FHC03444 50,000 MAK Serine/threonine-protein kinase MAK (EC 2.7.11.22)(Male germ cell-associated kinase) FXC03902 40,000 FHC03902 50,000 MAP2K1 mitogen-activated protein kinase kinase 1 FXC10375 40,000 FHC10375 50,000 MAP2K2 mitogen-activated protein kinase kinase 2 FXC05918 40,000 FHC05918 50,000 MAP2K3 mitogen-activated protein kinase kinase 3 FXC10525 40,000 FHC10525 50,000 MAP2K4 mitogen-activated protein kinase kinase 4 FXC25904M 50,000 FHC25904 50,000 MAP2K5 mitogen-activated protein kinase kinase 5 FXC01455 40,000 FHC01455 50,000 MAP2K6 mitogen-activated protein kinase kinase 6 FXC01384 40,000 FHC01384 50,000 MAP2K7 mitogen-activated protein kinase kinase 7 FXC11270 40,000 FHC11270 50,000 MAP3K10 mitogen-activated protein kinase kinase kinase 10 FXC11092M 50,000 FHC11092 50,000 MAP3K11 mitogen-activated protein kinase kinase kinase 11 FXC24308M 50,000 FHC24308 50,000 MAP3K12 mitogen-activated protein kinase kinase kinase 12, transcript variant 2 FXC24753M 50,000 FHC24753 50,000 MAP3K13 mitogen-activated protein kinase kinase kinase 13, transcript variant 1 FXC21785M 50,000 FHC21785 50,000 MAP3K2 mitogen-activated protein kinase kinase kinase 2 FXC01733 40,000 FHC01733 50,000 MAP3K3 mitogen-activated protein kinase kinase kinase 3 FXC02739 40,000 FHC02739 50,000 MAP3K4 mitogen-activated protein kinase kinase kinase 4 FXC05920M 50,000 FHC05920 50,000

MAP3K5 mitogen-activated protein kinase kinase kinase 5 FXC01323 40,000 FHC01323 50,000 MAP3K6 mitogen-activated protein kinase kinase kinase 6 FXC11020M 50,000 FHC11020 50,000 MAP3K7 mitogen-activated protein kinase kinase kinase 7 FXC10678 40,000 FHC10678 50,000 MAP3K8 Mitogen-activated protein kinase kinase kinase 8 (EC 2.7.11.25)(COT proto-oncogene serine/threonine-protein kinase)(cancer Osaka thyroid oncogene)(c-cot)(tumor FXC03793 40,000 FHC03793 50,000 progression locus 2)(TPL-2) MAP4K1 mitogen-activated protein kinase kinase kinase kinase 1 FXC05924 40,000 FHC05924 50,000 MAP4K3 mitogen-activated protein kinase kinase kinase kinase 3 FXC01352 40,000 FHC01352 50,000 MAP4K4 mitogen-activated protein kinase kinase kinase kinase 4 FXC00116 40,000 FHC00116 50,000 MAP4K5 mitogen-activated protein kinase kinase kinase kinase 5 FXC09594 40,000 FHC09594 50,000 MAPK1 mitogen-activated protein kinase 1 FXC01388 40,000 FHC01388 50,000 MAPK10 mitogen-activated protein kinase 10 FXC03139 40,000 FHC03139 50,000 MAPK11 mitogen-activated protein kinase 11 FXC02847 40,000 FHC02847 50,000 MAPK12 Mitogen-activated protein kinase 12 (EC 2.7.11.24)(Extracellular signal-regulated kinase 6)(ERK- 6)(ERK5)(Stress-activated protein kinase 3)(Mitogenactivated FXC05927 40,000 FHC05927 50,000 protein kinase p38 gamma)(map kinase p38 MAPK13 mitogen-activated protein kinase 13 FXC05928 40,000 FHC05928 50,000 MAPK14 mitogen-activated protein kinase 14 FXC01309 40,000 FHC01309 50,000 MAPK15 Mitogen-activated protein kinase 15 (EC 2.7.11.24)(Extracellular signal-regulated kinase 8) FXC10717 40,000 FHC10717 50,000 MAPK3 mitogen-activated protein kinase 3 FXC01500 40,000 FHC01500 50,000 MAPK4 mitogen-activated protein kinase 4 FXC29878M 50,000 FHC29878 50,000 MAPK6 mitogen-activated protein kinase 6 FXC01714 40,000 FHC01714 50,000 MAPK7 Mitogen-activated protein kinase 7 (EC 2.7.11.24)(Extracellular signal-regulated kinase 5)(ERK- FXC03754 40,000 FHC03754 50,000 5)(ERK4)(Big MAP kinase 1)(BMK1 kinase) MAPK8 Mitogen-activated protein kinase 8 (EC 2.7.11.24)(Stressactivated protein kinase JNK1)(c-Jun N-terminal kinase FXC03521 40,000 FHC03521 50,000 MAPK9 mitogen-activated protein kinase 9 FXC01315 40,000 FHC01315 50,000 MAPKAPK2 mitogen-activated protein kinase-activated protein kinase 2 FXC20795M 50,000 FHC20795 50,000 MAPKAPK3 mitogen-activated protein kinase-activated protein kinase 3 FXC11215 40,000 FHC11215 50,000 MARK1 MAP/microtubule affinity-regulating kinase 1 FXC00236 40,000 FHC00236 50,000 MARK3 MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1)(Cdc25C-associated protein kinase 1)(C- TAK1)(cTAK1)(Serine/threonine-protein kinase p78)(ser/thr FXC09142 40,000 FHC09142 50,000 protein kinase PAR-1)(Protein kinase STK10) MARK4 MAP/microtubule affinity-regulating kinase 4 FXC00935 40,000 FHC00935 50,000 MAST1 microtubule associated serine/threonine kinase 1 FXC00159 40,000 FHC00159 50,000 MAST3 microtubule associated serine/threonine kinase 3 FXC05934 40,000 FHC05934 50,000 MAST4 microtubule associated serine/threonine kinase family FXC00046 40,000 FHC00046 50,000 MATK megakaryocyte-associated tyrosine kinase FXC26396M 50,000 FHC26396 50,000 MERTK c-mer proto-oncogene tyrosine kinase FXC11823M 50,000 FHC11823 50,000 MINK1 misshapen-like kinase 1 FXC09529M 50,000 FHC09529 50,000 MKNK1 MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1)(MAP kinase signal-integrating kinase 1)(Mnk1) FXC10724 40,000 FHC10724 50,000 MKNK2 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1)(MAP kinase signal-integrating kinase 2)(Mnk2) FXC03791 40,000 FHC03791 50,000 MLKL Mixed lineage kinase domain-like protein FXC03959 40,000 FHC03959 50,000 MLTK Mitogen-activated protein kinase kinase kinase MLT FXC01289 40,000 FHC01289 50,000 MOS v-mos Moloney murine sarcoma viral oncogene homolog FXC03345 40,000 FHC03345 50,000 MUSK muscle, skeletal, receptor tyrosine kinase, transcript variant 1 FXC31275M 50,000 FHC31275 50,000 MYLK myosin light chain kinase FXC01214 40,000 FHC01214 50,000 MYLK2 myosin light chain kinase 2 FXC11428 40,000 FHC11428 50,000 MYLK4 myosin light chain kinase family, member 4 FXC11219 40,000 FHC11219 50,000 MYT1 myelin transcription factor 1 FXC01126 40,000 FHC01126 50,000 NEK1 NIMA (never in mitosis gene a)-related kinase 1 FXC01183 40,000 FHC01183 50,000 NEK10 NIMA (never in mitosis gene a)- related kinase 10 FXC21464M 90,000 FHC21464M 100,000 NEK11 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1)(Never in mitosis A-related kinase 11)(NimA-related protein kinase 11) FXC03904 40,000 FHC03904 50,000 NEK2 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1)(NimArelated protein kinase 2)(NimA-like protein kinase 1)(HSPK FXC03486 40,000 FHC03486 50,000 NEK3 NIMA (never in mitosis gene a)-related kinase 3 FXC11422 40,000 FHC11422 50,000 NEK6 NIMA (never in mitosis gene a)-related kinase 6 FXC01435 40,000 FHC01435 50,000 NEK7 NIMA (never in mitosis gene a)-related kinase 7 FXC11185 40,000 FHC11185 50,000 NEK9 NIMA (never in mitosis gene a)- related kinase 9 FXC02059 40,000 FHC02059 50,000 NLK Serine/threonine protein kinase NLK FXC01310 40,000 FHC01310 50,000 NRBP1 Nuclear receptor-binding protein FXC09761 40,000 FHC09761 50,000 NRBP2 nuclear receptor binding protein 2 FXC31650M 50,000 FHC31650 50,000 NTRK1 neurotrophic tyrosine kinase, receptor, type 1, transcript FXC20642M 50,000 FHC20642 50,000

NTRK2 neurotrophic tyrosine kinase, receptor, type 2 FXC07750 40,000 FHC07750 50,000 NTRK2 neurotrophic tyrosine kinase, receptor, type 2 FXC12007M 80,000 FHC12007M 90,000 NTRK3 neurotrophic tyrosine kinase, receptor, type 3 FXC01346 40,000 FHC01346 50,000 NUAK1 NUAK family, SNF1-like kinase, 1 FXC00556 40,000 FHC00556 50,000 NUAK2 NUAK family, SNF1-like kinase, 2 FXC02813 40,000 FHC02813 50,000 OSR1 odd-skipped related 1 (Drosophila) FXC10938M 50,000 FHC10938 50,000 PAK4 p21 protein (Cdc42/Rac)-activated kinase 4 FXC00749 40,000 FHC00749 50,000 PAK6 p21 protein (Cdc42/Rac)-activated kinase 6 FXC01015 40,000 FHC01015 50,000 PAK7 p21 protein (Cdc42/Rac)-activated kinase 7 FXC00788 40,000 FHC00788 50,000 PASK PAS domain containing serine/threonine kinase FXC00421 40,000 FHC00421 50,000 PBK PDZ binding kinase FXC11697 40,000 FHC11697 50,000 PDGFRB platelet-derived growth factor receptor, beta polypeptide FXC01574 40,000 FHC01574 50,000 PDIK1L PDLIM1 interacting kinase 1 like FXC01757 40,000 FHC01757 50,000 PDK1 [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial Precursor (EC 2.7.11.2)(Pyruvate FXC09662 40,000 FHC09662 50,000 dehydrogenase kinase isoform 1) PHKG2 phosphorylase kinase, gamma 2 (testis) FXC08078 40,000 FHC08078 50,000 PIM1 pim-1 oncogene FXC11400 40,000 FHC11400 50,000 PIM2 pim-2 oncogene FXC11257 40,000 FHC11257 50,000 PIM3 pim-3 oncogene FXC11261 40,000 FHC11261 50,000 PINK1 PTEN induced putative kinase 1 FXC01021 40,000 FHC01021 50,000 PKN1 Serine/threonine-protein kinase N1 (EC 2.7.11.13)(Protein kinase C-like 1)(Protein-kinase C-related kinase 1)(Protein FXC03745 40,000 FHC03745 50,000 kinase C-like PKN)(Serine-threonine protein kinase N)(Protein PKN2 Serine/threonine-protein kinase N2 (EC 2.7.11.13)(Protein kinase C-like 2)(Protein-kinase C-related kinase 2) FXC03784 40,000 FHC03784 50,000 PKN3 protein kinase N3 FXC23660M 50,000 FHC23660 50,000 PLK1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21)(Pololike kinase 1)(PLK-1)(Serine/threonine-protein kinase FXC08757 40,000 FHC08757 50,000 PLK2 polo-like kinase 2 (Drosophila) FXC01794 40,000 FHC01794 50,000 PLK4 polo-like kinase 4 FXC09597M 50,000 FHC09597 50,000 PNCK pregnancy up-regulated non-ubiquitously expressed CaM FXC11227 40,000 FHC11227 50,000 PRKAA1 protein kinase, AMP-activated, alpha 1 catalytic subunit, transcript variant 1 FXC22157M 50,000 FHC22157 50,000 PRKAA2 protein kinase, AMP-activated, alpha 2 catalytic subunit FXC20333M 50,000 FHC20333 50,000 PRKACA protein kinase, camp-dependent, catalytic, alpha FXC10564 40,000 FHC10564 50,000 PRKACB protein kinase, camp-dependent, catalytic, beta FXC02835 40,000 FHC02835 50,000 PRKACG protein kinase, camp-dependent, catalytic, gamma FXC06481 40,000 FHC06481 50,000 PRKCA Protein kinase C alpha type (PKC-alpha)(PKC-A)(EC FXC03611 40,000 FHC03611 50,000 PRKCB Protein kinase C beta type (PKC-beta)(PKC-B)(EC 2.7.11.13) FXC10533 40,000 FHC10533 50,000 PRKCD Protein kinase C delta type (EC 2.7.11.13)(nPKC-delta) FXC03651 40,000 FHC03651 50,000 PRKCE protein kinase C, epsilon FXC01866 40,000 FHC01866 50,000 PRKCG Protein kinase C gamma type (PKC-gamma)(EC 2.7.11.13) FXC03659 40,000 FHC03659 50,000 PRKCH protein kinase C, eta FXC01867 40,000 FHC01867 50,000 PRKCI protein kinase C, iota FXC21760M 50,000 FHC21760 50,000 PRKCQ Protein kinase C theta type (EC 2.7.11.13)(nPKC-theta) FXC03603 40,000 FHC03603 50,000 PRKCZ protein kinase C, zeta FXC06489 40,000 FHC06489 50,000 PRKG1 protein kinase, cgmp-dependent, type I FXC23849M 50,000 FHC23849 50,000 PRKG2 protein kinase, cgmp-dependent, type II FXC06491 40,000 FHC06491 50,000 PRKX protein kinase, X-linked FXC27284M 50,000 FHC27284 50,000 PRPF4B PRP4 pre-mrna processing factor 4 homolog B (yeast) FXC01088 40,000 FHC01088 50,000 PSKH1 protein serine kinase H1 FXC11260 40,000 FHC11260 50,000 PSKH2 protein serine kinase H2 FXC23327M 50,000 FHC23327 50,000 PTK2B Protein tyrosine kinase 2 beta (EC 2.7.10.2)(Focal adhesion kinase 2)(FADK 2)(Proline-rich tyrosine kinase 2)(Cell adhesion kinase beta)(cak beta)(calcium-dependent tyrosine FXC03522 40,000 FHC03522 50,000 kinase)(cadtk)(related adhesion focal tyrosine PTK6 Tyrosine-protein kinase 6 (EC 2.7.10.2)(Breast tumor kinase)(tyrosine-protein kinase BRK) FXC03489 40,000 FHC03489 50,000 RAF1 v-raf-1 murine leukemia viral oncogene homolog 1 FXC01412 40,000 FHC01412 50,000 RET ret proto-oncogene FXC01300 40,000 FHC01300 50,000 RIPK1 receptor (TNFRSF)-interacting serine-threonine kinase 1 FXC22422M 50,000 FHC22422 50,000 RIPK2 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1)(RIP-like-interacting CLARP kinase)(receptorinteracting protein 2)(RIP-2)(CARD-containing interleukin-1 FXC10504 40,000 FHC10504 50,000 beta-converting enzyme-associated kinase)(card-containing IL-1 beta ICE-kinase) ROCK1 Rho-associated, coiled-coil containing protein kinase 1 FXC26266M 50,000 FHC26266 50,000 ROCK2 Rho-associated, coiled-coil containing protein kinase 2 FXC01105 40,000 FHC01105 50,000 ROR1 receptor tyrosine kinase-like orphan receptor 1 FXC20341M 50,000 FHC20341 50,000 ROR2 receptor tyrosine kinase-like orphan receptor 2 FXC12087M 50,000 FHC12087 50,000

RPS6KA1 ribosomal protein S6 kinase, 90kDa, polypeptide 1 FXC01797 40,000 FHC01797 50,000 RPS6KA2 ribosomal protein S6 kinase, 90kDa, polypeptide 2 FXC01745 40,000 FHC01745 50,000 RPS6KA3 ribosomal protein S6 kinase, 90kDa, polypeptide 3 FXC01272 40,000 FHC01272 50,000 RPS6KA6 Ribosomal protein S6 kinase alpha-6 (S6K-alpha 6)(EC 2.7.11.1)(90 kda ribosomal protein S6 kinase 6)(p90-RSK FXC06696 40,000 FHC06696 50,000 6)(Ribosomal S6 kinase 4)(RSK-4)(pp90RSK4) RPS6KB1 ribosomal protein S6 kinase, 70kDa, polypeptide 1 FXC01400 40,000 FHC01400 50,000 RPS6KB2 ribosomal protein S6 kinase, 70kDa, polypeptide 2 FXC11419 40,000 FHC11419 50,000 RYK RYK receptor-like tyrosine kinase FXC11007 40,000 FHC11007 50,000 SBK1 SH3-binding domain kinase 1 FXC28376M 50,000 FHC28376 50,000 SBK2 Putative uncharacterized serine/threonine-protein kinase SgK069 (EC 2.7.11.1)(Sugen kinase 69) FXC03903 40,000 FHC03903 50,000 SCYL2 SCY1-like protein 2 (Coated vesicle-associated kinase of 104 FXC00814 40,000 FHC00814M 60,000 SCYL2 SCY1-like 2 (S. cerevisiae) FXC11487M 50,000 FHC11487 50,000 SGK2 serum/glucocorticoid regulated kinase 2 FXC01404 40,000 FHC01404 50,000 SGK3 serum/glucocorticoid regulated kinase family, member 3 FXC01791 40,000 FHC01791 50,000 SGK494 Uncharacterized serine/threonine-protein kinase SgK494(Sugen kinase 494) FXC11232 40,000 FHC11232 50,000 SIK1 salt-inducible kinase 1 FXC10354M 50,000 FHC10354 50,000 SNRK SNF related kinase FXC00407 40,000 FHC00407 50,000 SRC Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2)(pp60c-src)(p60-Src)(c-Src) FXC11854 40,000 FHC11854 50,000 SRPK1 SRSF protein kinase 1, transcript variant 1 FXC31137M 50,000 FHC31137 50,000 SRPK2 SFRS protein kinase 2 FXC07744 40,000 FHC07744 50,000 SRPK3 SFRS protein kinase 3 FXC07755 40,000 FHC07755 50,000 STK11 Serine/threonine-protein kinase 11 (EC 2.7.11.1)(Serine/threonine-protein kinase LKB1)(Renal FXC08358 40,000 FHC08358 50,000 STK16 serine/threonine kinase 16, transcript variant 1 FXC29997M 50,000 FHC29997 50,000 STK17A serine/threonine kinase 17a FXC22919M 50,000 FHC22919 50,000 STK24 serine/threonine kinase 24 (STE20 homolog, yeast) FXC09574M 50,000 FHC09574 50,000 STK25 serine/threonine kinase 25 (STE20 homolog, yeast) FXC11416 40,000 FHC11416 50,000 STK3 serine/threonine kinase 3 (STE20 homolog, yeast) FXC11390 40,000 FHC11390 50,000 STK32A Serine/threonine-protein kinase 32A (EC 2.7.11.1)(YANK1) FXC03969 40,000 FHC03969 50,000 STK32B serine/threonine kinase 32B FXC11252 40,000 FHC11252 50,000 STK33 Serine/threonine-protein kinase 33 (EC 2.7.11.1) FXC03932 40,000 FHC03932 50,000 STK35 Serine/threonine-protein kinase 35 (EC 2.7.11.1)(CLP-36- interacting kinase)(clik1)(pdlim1-interacting kinase 1) FXC03895 40,000 FHC03895 50,000 STK36 serine/threonine kinase 36, fused homolog (Drosophila) FXC09188M 50,000 FHC09188 50,000 STK38 serine/threonine kinase 38 FXC01016 40,000 FHC01016 50,000 STK38L serine/threonine kinase 38 like FXC00701 40,000 FHC00701 50,000 STK40 serine/threonine kinase 40 FXC02834 40,000 FHC02834 50,000 STRADB STE20-related kinase adaptor beta FXC21281M 50,000 FHC21281 50,000 STYK1 serine/threonine/tyrosine kinase 1 FXC02929 40,000 FHC02929 50,000 SYK spleen tyrosine kinase FXC01283 40,000 FHC01283 50,000 TAOK1 TAO kinase 1 FXC00219 40,000 FHC00219 50,000 TAOK2 TAO kinase 2 FXC00670 40,000 FHC00670 50,000 TAOK3 TAO kinase 3 FXC09805M 50,000 FHC09805 50,000 TBCK TBC1 domain containing kinase FXC08413M 50,000 FHC08413 50,000 TBK1 TANK-binding kinase 1 FXC31490M 50,000 FHC31490 50,000 TEC tec protein tyrosine kinase FXC11113M 50,000 FHC11113 50,000 TEK TEK tyrosine kinase, endothelial FXC01718 40,000 FHC01718 50,000 TESK2 testis-specific kinase 2 FXC11425 40,000 FHC11425 50,000 TGFBR1 transforming growth factor, beta receptor 1 FXC01305 40,000 FHC01305 50,000 TGFBR2 transforming growth factor, beta receptor II (70/80kDa) FXC01401 40,000 FHC01401 50,000 TIE1 tyrosine kinase with immunoglobulin-like and EGF-like FXC01852 40,000 FHC01852 50,000 TLK1 tousled-like kinase 1 FXC00422 40,000 FHC00422 50,000 TLK2 tousled-like kinase 2 FXC10799 40,000 FHC10799 50,000 TNIK TRAF2 and NCK interacting kinase FXC01090 40,000 FHC01090 50,000 TNK1 tyrosine kinase, non-receptor, 1 FXC09586M 50,000 FHC09586 50,000 TNNI3K TNNI3 interacting kinase FXC20376M 50,000 FHC20376 50,000 TRIB1 tribbles homolog 1 (Drosophila) FXC01553 40,000 FHC01553 50,000 TRIB2 tribbles homolog 2 (Drosophila) FXC11413 40,000 FHC11413 50,000 TRIB3 tribbles homolog 3 (Drosophila) FXC10581 40,000 FHC10581 50,000 TRIO triple functional domain (PTPRF interacting) FXC22132M 50,000 FHC22132 50,000 TSSK1B Testis-specific serine/threonine-protein kinase 1 FXC02252 40,000 FHC02252 50,000 TSSK2 testis-specific serine kinase 2 FXC02969 40,000 FHC02969 50,000 TSSK3 testis-specific serine kinase 3 FXC11410 40,000 FHC11410 50,000 TSSK4 Testis-specific serine/threonine-protein kinase 4 (TSSK- 4)(Testis-specific kinase 4)(TSK-4)(EC FXC03938 40,000 FHC03938 50,000 2.7.11.1)(Serine/threonine-protein kinase 22E) TSSK6 testis-specific serine kinase 6 FXC03019 40,000 FHC03019 50,000

TTBK2 tau tubulin kinase 2 FXC01676 40,000 FHC01676 50,000 TTK TTK protein kinase FXC07900M 80,000 FHC07900M 90,000 TXK TXK tyrosine kinase FXC21911M 50,000 FHC21911 50,000 TYK2 tyrosine kinase 2 FXC10017M 50,000 FHC10017 50,000 TYRO3 TYRO3 protein tyrosine kinase FXC01402 40,000 FHC01402 50,000 UHMK1 U2AF homology motif (UHM) kinase 1 FXC01741 40,000 FHC01741 50,000 ULK1 unc-51-like kinase 1 (C. elegans) FXC00613 40,000 FHC00613 50,000 ULK2 unc-51-like kinase 2 (C. elegans) FXC01106 40,000 FHC01106 50,000 ULK3 unc-51-like kinase 3 (C. elegans) FXC11211 40,000 FHC11211 50,000 VRK1 vaccinia related kinase 1 FXC11229 40,000 FHC11229 50,000 VRK2 vaccinia related kinase 2 FXC11707 40,000 FHC11707 50,000 WEE1 WEE1 homolog (S. pombe) FXC01243 40,000 FHC01243 50,000 WNK1 WNK lysine deficient protein kinase 1 FXC12495M 50,000 FHC12495 50,000 WNK2 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1)(Protein kinase with no lysine 2)(Protein kinase, lysine-deficient FXC02051 40,000 FHC02051 50,000 2)(Serologically defined colon cancer antigen 43)(Antigen NY- WNK3 WNK lysine deficient protein kinase 3 FXC11560M 50,000 FHC11560 50,000 YES1 v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 FXC01863 40,000 FHC01863 50,000 ZAP70 Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2)(70 kda zetaassociated protein)(syk-related tyrosine kinase) FXC03901 40,000 FHC03901 50,000